TNYA Annual Cash & Cash Equivalents
$45.68 M
-$49.59 M-52.05%
31 December 2023
Summary:
As of January 23, 2025, TNYA annual cash & cash equivalents is $45.68 million, with the most recent change of -$49.59 million (-52.05%) on December 31, 2023. During the last 3 years, it has fallen by -$82.85 million (-64.46%). TNYA annual cash & cash equivalents is now -64.46% below its all-time high of $128.53 million, reached on December 31, 2020.TNYA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNYA Quarterly Cash And Cash Equivalents
$8.23 M
-$49.90 M-85.84%
30 September 2024
Summary:
As of January 23, 2025, TNYA quarterly cash and cash equivalents is $8.23 million, with the most recent change of -$49.90 million (-85.84%) on September 30, 2024. Over the past year, it has dropped by -$73.92 million (-89.98%). TNYA quarterly cash and cash equivalents is now -93.60% below its all-time high of $128.53 million, reached on December 1, 2020.TNYA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNYA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.0% | -90.0% |
| 3 y3 years | -64.5% | -90.0% |
| 5 y5 years | +91.4% | -90.0% |
TNYA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.0% | +19.8% | -91.4% | at low |
| 5 y | 5-year | -64.5% | +91.4% | -93.6% | at low |
| alltime | all time | -64.5% | +91.4% | -93.6% | at low |
Tenaya Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.23 M(-85.8%) |
| June 2024 | - | $58.13 M(-2.0%) |
| Mar 2024 | - | $59.30 M(+29.8%) |
| Dec 2023 | $45.68 M(-52.1%) | $45.68 M(-44.4%) |
| Sept 2023 | - | $82.15 M(+8.7%) |
| June 2023 | - | $75.56 M(+4.2%) |
| Mar 2023 | - | $72.54 M(-23.9%) |
| Dec 2022 | $95.27 M | $95.27 M(+176.2%) |
| Sept 2022 | - | $34.49 M(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $31.01 M(+19.4%) |
| Mar 2022 | - | $25.97 M(-31.9%) |
| Dec 2021 | $38.13 M(-70.3%) | $38.13 M(-67.4%) |
| Sept 2021 | - | $117.08 M(+4.6%) |
| June 2021 | - | $111.89 M(-12.9%) |
| Mar 2021 | - | $128.44 M(-0.1%) |
| Dec 2020 | $128.53 M(+438.4%) | - |
| Dec 2020 | - | $128.53 M |
| Dec 2019 | $23.87 M | - |
FAQ
- What is Tenaya Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tenaya Therapeutics?
- What is Tenaya Therapeutics annual cash & cash equivalents year-on-year change?
- What is Tenaya Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Tenaya Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TNYA is $45.68 M
What is the all time high annual cash & cash equivalents for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual cash & cash equivalents is $128.53 M
What is Tenaya Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TNYA annual cash & cash equivalents has changed by -$49.59 M (-52.05%)
What is Tenaya Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TNYA is $8.23 M
What is the all time high quarterly cash and cash equivalents for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly cash and cash equivalents is $128.53 M
What is Tenaya Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TNYA quarterly cash and cash equivalents has changed by -$73.92 M (-89.98%)